Please ensure Javascript is enabled for purposes of website accessibility

Express Scripts Holding Beats on Revenue, Matches Expectations on EPS

By Seth Jayson - Updated Apr 10, 2017 at 1:34PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Just the facts, Fool.

Express Scripts Holding (Nasdaq: ESRX) reported earnings on April 29. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Express Scripts Holding beat expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly. Non-GAAP earnings per share grew significantly. GAAP earnings per share dropped significantly.

Gross margins increased, operating margins dropped, net margins contracted.

Revenue details
Express Scripts Holding reported revenue of $26.06 billion. The 20 analysts polled by S&P Capital IQ anticipated a top line of $25.50 billion on the same basis. GAAP reported sales were much higher than the prior-year quarter's $12.13 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.99. The 23 earnings estimates compiled by S&P Capital IQ forecast $0.98 per share. Non-GAAP EPS of $0.99 for Q1 were 36% higher than the prior-year quarter's $0.73 per share. GAAP EPS of $0.45 for Q1 were 18% lower than the prior-year quarter's $0.55 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 7.5%, 60 basis points better than the prior-year quarter. Operating margin was 3.2%, 170 basis points worse than the prior-year quarter. Net margin was 1.4%, 80 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $25.34 billion. On the bottom line, the average EPS estimate is $1.05.

Next year's average estimate for revenue is $100.90 billion. The average EPS estimate is $4.26.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 788 members out of 836 rating the stock outperform, and 48 members rating it underperform. Among 224 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 214 give Express Scripts Holding a green thumbs-up, and 10 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Express Scripts Holding is outperform, with an average price target of $64.22.

Is Express Scripts Holding the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Express Scripts Holding Company Stock Quote
Express Scripts Holding Company
ESRX

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.